ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute LeukemiaKirsten Dickerson, Charles G. Mullighan, Chunxu Qu et al.|Blood Cancer Discovery|2022Cited by 37
Venetoclax plus gilteritinib is effective in preclinical models of <i>FLT3</i> -mutant BCL11B-a lineage-ambiguous leukemiaLindsey E. Montefiori, Charles G. Mullighan, Amit Budhraja et al.|Blood|2025Cited by 7
G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALLIlaria Iacobucci, Charles G. Mullighan, Reiji Fukano et al.|Blood Advances|2022Cited by 3
Poster: AML-144 Uroporphyrinogen Decarboxylase (UROD) Is a Therapeutically Targetable Dependency in Acute Erythroid LeukemiaJake D. Friske, Ilaira Iacobucci, Yu Fukuda et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 0
Data from ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute LeukemiaKirsten Dickerson, Charles G. Mullighan, Chunxu Qu et al.|Unknown|2023Cited by 0